Portrait photo of UQ Professor Trent Munro wearing a white coat in a laboratory. Supplied.

Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company — potentially changing the lives of millions of people.

4 November 2022

University of Queensland experts are available to comment on pain in conjunction with Pain Week. Journalists can contact the following experts below or search by topic or name at UQ Experts.

24 July 2018

University of Queensland pain drug pioneer Professor Maree Smith has joined an elite group of scientists tonight, receiving the prestigious ATSE Clunies Ross Award.

16 June 2016
Professor Maree Smith (centre), with Johnson & Johnson Medical CEO Gavin Fox-Smith and AusBiotech CEO Dr Anna Lavelle

The University of Queensland’s Professor Maree Smith and the company founded on the ground-breaking pain drug she developed have won awards at the AusBiotech 2015 Conference.

7 October 2015
Ashton “Little Superman” Hancock, has hypoplasia of the corpus callosum, resulting in epilepsy and hearing impairment

Do you know where your corpus callosum is located? A University of Queensland researcher is on a mission to make sure more people know about the central brain structure by supporting National Corpus Callosum Awareness Day on 2 July.

1 July 2015
UQ pain researcher Professor Maree Smith.

A chronic pain treatment discovered at The University of Queensland is a step closer to clinical use with a global pharmaceutical giant acquiring the Australian-founded company developing the drug.

29 June 2015

Queensland will soon be home to a major initiative to discover and develop new drugs to combat health issues including cancer, diabetes, inflammatory disorders and infectious diseases.

16 June 2015
Research leader Professor Maree Smith

An Australian company developing a chronic pain treatment based on research at The University of Queensland (UQ) has attracted US$45 million (AU$48M) to advance development of the drug, EMA401.

11 April 2014

A collaborative research project aimed at discovering a drug to treat a highly resistant form of breast cancer is one of two projects given the green light by the Queensland Emory Development (QED) Alliance.

7 November 2013